Biosprendimų laboratorija, UAB Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 162,489 |
| 54,163 |
| 46,300 |
| 46,300 |
| 15,433 |
| 68.65 |
| 28.49 |
| 137,211 |
| 265,824 |
| 993 |
| 402,042 |
| 2024 |
|---|
| 195,431 |
| 53,396 |
| 41,333 |
| 41,333 |
| 11,293 |
| 59.31 |
| 21.15 |
| 180,498 |
| 242,134 |
| 23,601 |
| 398,495 |
| 2025 |
|---|
| 95,447 |
| 24,537 |
| -20,748 |
| -20,748 |
| -5,334 |
| 57.32 |
| -21.74 |
| 185,793 |
| 128,681 |
| 20,626 |
| 292,398 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 95,447 |
| 24,537 |
| -20,748 |
| -20,748 |
| -5,334 |
| 57.32 |
| -21.74 |
| 185,793 |
| 128,681 |
| 20,626 |
| 292,398 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
95,447 €-51 % *
Sales per employee (€)
24,537 €-54 % *
Profit before tax (€)
-20,748 €-150 % *
Net Profit (€)
-20,748 €-150 % *
Profit per employee (€)
-5,334 €-147 % *
Total profitability (%)
57.32 %-3.36 % *
Net profitability (%)
-21.74 %-202.79 % *
Equity (€)
185,793 €3 % *
Amounts Payable And Liabilities (€)
128,681 €-47 % *
Non-current Assets (€)
20,626 €-13 % *
CurrentAssets (€)
292,398 €-27 % *
